Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
April is national oral, head, and neck cancer awareness month.
Toripalimab (Loqtorzi) is the first immunotherapy drug approved for nasopharyngeal carcinoma, a type of head and neck cancer.
EBV causes chromosome breakage that can trigger a cascade of genomic instability leading to tumor growth.
A collaboration explores canine sinonasal carcinoma with the aim of better treatment options for humans — and our canine companions.
Other studies focused on bladder cancer, prostate cancer and liquid biopsies.
Dana-Farber researchers use artificial intelligence to efficiently diagnose muscle wasting in patients with head and neck cancers.
Using a targeted approach, researchers slowed head and neck cancer growth in mice.
New research shows PD-L1 interaction can alter cancer intrinsic signaling in head and neck cancer, among others.
The National Comprehensive Cancer Network (NCCN) developed a global roadmap for improving thyroid cancer care.
In a head-to-head comparison, three experimental vaccines eradicated HPV-related cancers in mice.
Several head and neck cancers were included among conditions presumed to be caused by exposure to toxic substances, including burn pits.
Laying the groundwork for using dogs with naturally occurring cancer as therapeutic models for human head and neck cancers.
The human papillomavirus (HPV) genome can insert itself into host chromosomes and “turn on” tumor-causing genes.
Antonio Jimeno, MD, PhD, led research studying a cell squeezing process used to treat a subtype of HPV16-driven head and neck cancer.
Thanks to groundbreaking immunotherapy research, Jane Hart enjoys every day without laryngeal cancer.
The tennis star’s HPV-related throat cancer could be related to her previous breast cancer, says Jessica McDermott, MD.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.